Effects of DNA methylation on galectin-3 expression in pituitary tumors

Cancer Research

Volumn 65, Issue 4, 2005, Pages 1136-1140

  Ruebel, Katharina H ^a   Jin, Long ^a   Qian, Xiang ^a   Scheithauer, Bernd W ^a   Kovacs, Kalman ^b   Nakamura, Nobuki ^a   Zhang, Heyu ^a   Raz, Avraham ^c   Lloyd, Ricardo V ^a  

^a Mayo Clinic College of Medicine   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CORTICOTROPIN; DNA; FOLLITROPIN; GALECTIN 3; LUTEINIZING HORMONE; MESSENGER RNA; PROLACTIN;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CARCINOMA CELL; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; DNA SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; HYPOPHYSIS TUMOR; METASTASIS; NULL CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; THYROID CARCINOMA;

ADENOMA; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; GALECTIN 3; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; PITUITARY NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 13944260094     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3578     Document Type: Article

References (20)

1. Barondes SH, Cooper DN, Gitt MA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994;269:20807-10.
2. Amado M, Almeida R, Schwientek T, Clausen H. Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta 1999;1473:35-53.
3. 2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res 1999;59:6239-45.
4. Honjo Y, Inohara H, Akahani S, et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 2000;6:4635-40.
5. Francois C, van Velthoven R, De Lathouwer O, et al. Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. Am J Clin Pathol 1999;112:194-203.
6. Xu XC, el-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 1995;147:815-22.
7. Inohara H, Akahani S, Koths K, Raz A. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res 1996;56:4530-4.
8. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 2002;277:6852-7.
9. Riss D, Jin L, Qian X, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res 2003;63:2251-5.
10. Kadrofske MM, Openo KP, Wang JL. The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch Biochem Biophys 1998;349:7-20.
11. Jin L, Qian X, Kulig E, et al. Transforming growth factor-β, transforming growth factor-β receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 1997;151:509-19.
12. Lahm H, Andre S, Hoeflich A, et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 2001;127:375-86.
13. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54.
14. Benvenuto G, Carpentieri ML, Salvatore P, Cindolo L, Bruni CB, Chiariotti L. Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. Mol Cell Biol 1996;16:2736-43.
15. Moisan S, Demers M, Mercier J, Magnaldo T, Potworowski EF, St-Pierre Y. Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia 2003;17:751-9.
16. Arar C, Gaudin JC, Capron L, Legrand A. Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells. FEBS Lett 1998;430:307-11.
17. Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 1997;79:804-12.
18. Lloyd RV. Molecular pathology of pituitary adenomas. J Neurooncol 2001;54:111-9.
19. Farrell WE, Clayton RN. Epigenetic change in pituitary tumorigenesis. Endocr Relat Cancer 2003;10:323-30.
20. Kumar V, Biswas DK. Dynamic state of site-specific DNA methylation concurrent to altered prolactin and growth hormone gene expression in the pituitary gland of pregnant and lactating rats. J Biol Chem 1988;263:12645-52.